Crédit Agricole PE et al. invest €7.5m in EyeTechCare

Crédit Agricole provided €4.5m while SHAM invested €3m. EyeTechcare had already raised €1.2m in 2008 from Crédit Agricole PE and CEA-Investissement. The new funds will be used to complete the first clinical trial on humans, as well as establish the manufacturing facilities and the sales and marketing force required for the company's first product.

EyeTechCare was founded in 2008 and is based in Rillieux-la-Pape, near Lyon. It specialises in non-invasive therapeutic medical devices using ultrasound technology. The company is currently developing a novel ultrasound-based medical device for the treatment of glaucoma. Its market launch is scheduled for early 2011.

The unquote" team is currently researching this transaction. In-depth deal information for subscribers will follow shortly.

If you have any information regarding this transaction, please contact Grégoire Gille on +44 20 7484 9824 or gregoire.gille@incisivemedia.com

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• France
• Benelux
• UK / Ireland
• DACH
• Nordics
• Southern Europe
• CEE
• Healthcare
• Early-stage
• France